CIK 0001701541 · Non-accelerated filer<br>Smaller reporting company
Black Diamond Therapeutics, Inc.
Sign in to watch- Ticker
- BDTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 814254660
- Phone
- 617-417-5868
- Business address
- 245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- Aset Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | Raman Prakash Director | Grant or award · Stock Option (Right to Buy) | +30,550 | 30,550 | ||
| 2024-06-06 | Campbell Shannon Director | Grant or award · Stock Option (Right to Buy) | +30,550 | 30,550 | ||
| 2024-06-06 | Dhingra Kapil Director | Grant or award · Stock Option (Right to Buy) | +30,550 | 30,550 | ||
| 2024-06-06 | Behbahani Ali Director | Grant or award · Stock Option (Right to Buy) | +30,550 | 30,550 | ||
| 2024-04-10 | Campbell Shannon Director | Grant or award · Stock Option (Right to Buy) | +61,100 | 61,100 | ||
| 2024-04-10 | Raman Prakash Director | Grant or award · Stock Option (Right to Buy) | +61,100 | 61,100 | ||
| 2024-03-15 | DIXON WENDY L Director | Grant or award | +3,253 | $4.54 | $15K | 38,054 |
| 2024-03-15 | Behbahani Ali Director | Grant or award | +3,166 | $4.54 | $14K | 51,690 |
| 2024-02-14 | Ni Fang SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2024-02-14 | Hatzis-Schoch Brent SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2024-02-14 | Yurasov Sergey CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2024-02-14 | Buck Elizabeth CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2024-02-14 | Velleca Mark A. PRESIDENT & CEO | Grant or award · Stock Option (Right to Buy) | +537,000 | 537,000 | ||
| 2024-02-14 | Jones Erika SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2023-12-15 | DIXON WENDY L Director | Grant or award | +4,043 | $2.73 | $11K | 34,801 |
| 2023-12-15 | Behbahani Ali Director | Grant or award | +4,455 | $2.73 | $12K | 48,524 |
| 2023-10-17 | BIOTECH GROWTH N V 10% owner | Purchase | +400,000 | $2.34 | $934K | 8,517,839 |
| 2023-09-17 | Velleca Mark A. PRESIDENT & CEO | Grant or award · Stock Option (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2023-09-15 | Velleca Mark A. PRESIDENT & CEO | Grant or award | +5,208 | $3.60 | $19K | 46,522 |
| 2023-09-15 | DIXON WENDY L Director | Grant or award | +2,986 | $3.60 | $11K | 30,758 |
Page 4 of 6 · 114 trades